Postremission nonhematologic NCI grade 3-4 toxicity from CCG-2891
| Affected organ or system . | Allogeneic BMT . | Autologous BMT . | Chemotherapy . | P value for homogeneity . | |||
|---|---|---|---|---|---|---|---|
| n = 181 No. (%) . | P value (allo vs auto) . | n = 177 No. (%) . | P value (auto vs chemo) . | n = 179 No. (%) . | P value (chemo vs allo) . | ||
| Gastrointestinal tract | 47 (26) | .04 | 30 (17) | < .01 | 15 (8) | < .0001 | < .01 |
| Liver | 59 (33) | < .0001 | 16 (9) | .82 | 15 (8) | < .0001 | < .01 |
| Lungs | 6 (3) | .16 | 2 (1) | .0002 | 19 (14) | .006 | < .01 |
| Heart | 4 (2) | .72 | 3 (2) | .03 | 11 (6) | .06 | .04 |
| Central nervous system | 3 (2) | .98 | 3 (2) | .64 | 2 (1) | .66 | .91 |
| Infection, any | 72 (40) | .54 | 76 (43) | < .0001 | 116 (65) | < .0001 | .001 |
| Infection, bacteremia/sepsis | 47 (26) | .19 | 57 (32) | < .0001 | 97 (54) | < .0001 | .001 |
| Affected organ or system . | Allogeneic BMT . | Autologous BMT . | Chemotherapy . | P value for homogeneity . | |||
|---|---|---|---|---|---|---|---|
| n = 181 No. (%) . | P value (allo vs auto) . | n = 177 No. (%) . | P value (auto vs chemo) . | n = 179 No. (%) . | P value (chemo vs allo) . | ||
| Gastrointestinal tract | 47 (26) | .04 | 30 (17) | < .01 | 15 (8) | < .0001 | < .01 |
| Liver | 59 (33) | < .0001 | 16 (9) | .82 | 15 (8) | < .0001 | < .01 |
| Lungs | 6 (3) | .16 | 2 (1) | .0002 | 19 (14) | .006 | < .01 |
| Heart | 4 (2) | .72 | 3 (2) | .03 | 11 (6) | .06 | .04 |
| Central nervous system | 3 (2) | .98 | 3 (2) | .64 | 2 (1) | .66 | .91 |
| Infection, any | 72 (40) | .54 | 76 (43) | < .0001 | 116 (65) | < .0001 | .001 |
| Infection, bacteremia/sepsis | 47 (26) | .19 | 57 (32) | < .0001 | 97 (54) | < .0001 | .001 |